More News

04 Aug 2007 Teva Announces Approval Of Generic Protonix(R) Delayed Release Tablets, 20 Mg And 40 Mg
04 Aug 2007 Abraxis BioScience Receives FDA Approval for Caffeine Citrate Injection USP, 20 mg/mL
04 Aug 2007 Hana Biosciences Initiates Marqibo(R) Phase 2 Clinical Trial in Relapsed Acute Lymphoblastic Leukemia (All)
04 Aug 2007 STADA acquires Russian pharma group MAKIZ for approx. EUR 125 million
03 Aug 2007 Hana Biosciences Licenses North American Commercial Rights for Zensana(TM) to Par Pharmaceutical in a $50 Million Deal
03 Aug 2007 Santhera and Takeda Extend European Marketing Collaboration for SNT-MC17 into Duchenne Muscular Dystrophy
03 Aug 2007 Genmab regains rights to HuMax-TAC
03 Aug 2007 GTC Biotherapeutics and LFB Biotechnologies developing CD20 Antibody
03 Aug 2007 Genentech Announces Expiration of Hart-Scott-Rodino Waiting Period and Completes Acquisition of Tanox
03 Aug 2007 Boston Scientific Provides Strategic Update
02 Aug 2007 Reorganisation of Astellas European Business Functions
02 Aug 2007 Takeda to License CCR5 Antagonists for Treatment of HIV Infection to Tobira Therapeutics, Inc.
02 Aug 2007 Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
02 Aug 2007 Nuvelo Reduces Expenses and Realigns Organization To Focus on Programs Expected To Yield Nearest-Term Proof-of-Concept Data
02 Aug 2007 Anadys Pharmaceuticals Announces Strategic Restructuring and Reports Second Quarter 2007 Financial Results
01 Aug 2007 Micrus Endovascular Signs Letter of Intent to Acquire Revascularization Technology to Treat Ischemic Stroke
01 Aug 2007 Johnson & Johnson Plans to Improve Overall Cost Structure, While Continuing to Invest in Opportunities for Sustained Profitable Growth
01 Aug 2007 Neuren to obtain late stage compound through Hamilton Pharmaceuticals acquisition
01 Aug 2007 FDA Advisory Panel votes 22 to 1 for Avandia(R) to remain available to patients in the US
01 Aug 2007 Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology
28 Jul 2007 Eisai Enters into In-licensing Agreement with Sepracor for Eszopiclone Insomnia Treatment
28 Jul 2007 ReNeuron acquires business assets of AmCyte Inc. for $4m. 27/07/07
28 Jul 2007 Medtronic to Acquire Kyphon for $3.9 Billion
28 Jul 2007 OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
28 Jul 2007 GlaxoSmithKline and Targacept Form Alliance in Therapeutics for CNS-related Disorders

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up